
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15114593
[patent_doc_number] => 20190343929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => COMBINED THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE VI (MAROTEAUX-LAMY-SYNDROME)
[patent_app_type] => utility
[patent_app_number] => 16/331358
[patent_app_country] => US
[patent_app_date] => 2017-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331358 | COMBINED THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE VI (MAROTEAUX-LAMY-SYNDROME) | Sep 8, 2017 | Abandoned |
Array
(
[id] => 17769389
[patent_doc_number] => 11401317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Human-CD123-targeting chimeric receptor ligand and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/329739
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 7941
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329739 | Human-CD123-targeting chimeric receptor ligand and application thereof | Aug 30, 2017 | Issued |
Array
(
[id] => 17080578
[patent_doc_number] => 20210275584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => IMMUNE CELL COMPOSITIONS AND METHODS OF USE FOR TREATING VIRAL AND OTHER INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/329142
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -166
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329142 | Immune cell compositions and methods of use for treating viral and other infections | Aug 28, 2017 | Issued |
Array
(
[id] => 13063195
[patent_doc_number] => 10052367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Compositions and methods for treating pathological calcification and ossification
[patent_app_type] => utility
[patent_app_number] => 15/686972
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 28
[patent_no_of_words] => 25779
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15686972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/686972 | Compositions and methods for treating pathological calcification and ossification | Aug 24, 2017 | Issued |
Array
(
[id] => 12680890
[patent_doc_number] => 20180118796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => METHOD FOR PRODUCING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 15/685053
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685053 | Method for producing protein | Aug 23, 2017 | Issued |
Array
(
[id] => 14464431
[patent_doc_number] => 20190183855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS
[patent_app_type] => utility
[patent_app_number] => 16/323720
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323720 | COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS | Aug 9, 2017 | Abandoned |
Array
(
[id] => 17267740
[patent_doc_number] => 11193155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Designer a 6-fucosidase mutants enable direct core fucosylation of intact N-glycopeptides and N-glycoproteins
[patent_app_type] => utility
[patent_app_number] => 16/323355
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11255
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323355 | Designer a 6-fucosidase mutants enable direct core fucosylation of intact N-glycopeptides and N-glycoproteins | Aug 9, 2017 | Issued |
Array
(
[id] => 12975892
[patent_doc_number] => 20170340714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 15/672899
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672899
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672899 | Compositions for treating pathological calcification conditions, and methods using same | Aug 8, 2017 | Issued |
Array
(
[id] => 12057189
[patent_doc_number] => 20170333533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'Compositions and Methods for Treating Pathological Calcification and Ossification'
[patent_app_type] => utility
[patent_app_number] => 15/671287
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26697
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671287
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671287 | Compositions and Methods for Treating Pathological Calcification and Ossification | Aug 7, 2017 | Abandoned |
Array
(
[id] => 14929861
[patent_doc_number] => 20190300568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => ALKALINE STABLE FC-BINDING PROTEINS FOR AFFINITY CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 16/324842
[patent_app_country] => US
[patent_app_date] => 2017-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324842 | Alkaline stable Fc-binding proteins for affinity chromatography | Aug 6, 2017 | Issued |
Array
(
[id] => 15055337
[patent_doc_number] => 10457959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Efficient selectivity of recombinant proteins
[patent_app_type] => utility
[patent_app_number] => 15/664444
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 13564
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664444
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/664444 | Efficient selectivity of recombinant proteins | Jul 30, 2017 | Issued |
Array
(
[id] => 12814216
[patent_doc_number] => 20180163242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => GLYCOSYL HYDROLASE ENZYMES AND USES THEREOF FOR BIOMASS HYDROLYSIS
[patent_app_type] => utility
[patent_app_number] => 15/647775
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/647775 | GLYCOSYL HYDROLASE ENZYMES AND USES THEREOF FOR BIOMASS HYDROLYSIS | Jul 11, 2017 | Abandoned |
Array
(
[id] => 15469111
[patent_doc_number] => 10550420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence
[patent_app_type] => utility
[patent_app_number] => 15/644876
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 27879
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644876
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/644876 | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence | Jul 9, 2017 | Issued |
Array
(
[id] => 14836787
[patent_doc_number] => 20190276794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHOD FOR THE FERMENTATIVE PRODUCTION OF MOLECULES OF INTEREST BY MICROORGANISMS COMPRISING GENES CODING SUGAR PHOSPHOTRANSFERASE SYSTEM (PTS)
[patent_app_type] => utility
[patent_app_number] => 16/315977
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315977 | Method for the fermentative production of molecules of interest by microorganisms comprising genes coding sugar phosphotransferase system (PTS) | Jul 5, 2017 | Issued |
Array
(
[id] => 13702667
[patent_doc_number] => 20170362288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => COLON AND PANCREAS CANCER PEPTIDOMIMETICS
[patent_app_type] => utility
[patent_app_number] => 15/633184
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15633184
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/633184 | Colon and pancreas cancer peptidomimetics | Jun 25, 2017 | Issued |
Array
(
[id] => 15634927
[patent_doc_number] => 10590442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Method for producing C4 dicarboxylic acid
[patent_app_type] => utility
[patent_app_number] => 16/313547
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10726
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313547 | Method for producing C4 dicarboxylic acid | Jun 21, 2017 | Issued |
Array
(
[id] => 11988011
[patent_doc_number] => 20170292166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'NOVEL METHODS FOR ENZYME MEDIATED POLYPEPTIDE CONJUGATION'
[patent_app_type] => utility
[patent_app_number] => 15/625975
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10000
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15625975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/625975 | Methods for enzyme mediated polypeptide conjugation | Jun 15, 2017 | Issued |
Array
(
[id] => 13699771
[patent_doc_number] => 20170360840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => EXTRACELLULAR VESICLES WITH ENHANCED POTENCY
[patent_app_type] => utility
[patent_app_number] => 15/625961
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15625961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/625961 | EXTRACELLULAR VESICLES WITH ENHANCED POTENCY | Jun 15, 2017 | Abandoned |
Array
(
[id] => 17680053
[patent_doc_number] => 11364284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Methods of treating myointimal proliferation
[patent_app_type] => utility
[patent_app_number] => 16/309047
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 53
[patent_no_of_words] => 15789
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309047 | Methods of treating myointimal proliferation | Jun 14, 2017 | Issued |
Array
(
[id] => 11979350
[patent_doc_number] => 20170283505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA'
[patent_app_type] => utility
[patent_app_number] => 15/623226
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 27628
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15623226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/623226 | PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA | Jun 13, 2017 | Abandoned |